Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Not yet recruiting × HIV Infections × Clear all

Phase

Phase NA 2 Phase 3 1 Phase 2/3 1

Status

Completed 12 Unknown 3 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 37 Carcinoma, Non-Small-Cell Lung 23 Colorectal Neoplasms 13 Neoplasms 12 Leukemia, Myeloid, Acute 11 Rectal Neoplasms 10 Lung Neoplasms 10 Nasopharyngeal Carcinoma 9 Stomach Neoplasms 8 Carcinoma, Hepatocellular 8 Squamous Cell Carcinoma of Head and Neck 7 Small Cell Lung Carcinoma 7 Prostatic Neoplasms 7 Uterine Cervical Neoplasms 6 Recurrence 6 Ovarian Neoplasms 6 Non-Muscle Invasive Bladder Neoplasms 6 Multiple Myeloma 6 Glioblastoma 6 Esophageal Squamous Cell Carcinoma 6 Esophageal Neoplasms 6 Pancreatic Neoplasms 5 Carcinoma, Renal Cell 5 Brain Neoplasms 5 Urinary Bladder Neoplasms 4 Polycystic Ovary Syndrome 4 Neoplasm Metastasis 4 Colonic Neoplasms 4 Triple Negative Breast Neoplasms 3 Lymphoma, Follicular 3

Interventions

Papillomavirus Vaccines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05173324 2022-08-03

H2VICTORY

International Agency for Research on Cancer

Phase 3 Not yet recruiting

HIV Infections, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡